110 likes | 270 Views
“Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review – 2014”, provides an overview of the Ajinomoto Pharmaceuticals Co., Ltd.s pharmaceutical research and development focus. For more details : http://goo.gl/ZX9qkw
E N D
Aarkstore - Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2014 www.aarkstore.com
Summary “Alzheimer's Disease - Pipeline Review, H2 2014”, provides an overview of the Alzheimer's Diseases therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alzheimer's Diseaseand special features on late-stage and discontinued projects. www.aarkstore.com
Scope - The report provides a snapshot of the global therapeutic landscape of Alzheimer's Disease- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Alzheimer's Disease and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Alzheimer's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects www.aarkstore.com
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Alzheimer's Disease- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Alzheimer's Disease pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope www.aarkstore.com
Table of Contents IntroductionAlzheimer's Disease OverviewTherapeutics DevelopmentAlzheimer's Disease - Therapeutics under Development by CompaniesAlzheimer's Disease - Therapeutics under Investigation by Universities/InstitutesAlzheimer's Disease - Pipeline Products GlanceAlzheimer's Disease - Products under Development by CompaniesAlzheimer's Disease - Products under Investigation by Universities/InstitutesAlzheimer's Disease - Companies Involved in Therapeutics DevelopmentAlzheimer's Disease - Therapeutics AssessmentDrug Profiles www.aarkstore.com
List Of Tables Number of Products under Development for Alzheimer's Disease, H2 2014Number of Products under Development for Alzheimer's Disease - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Comparative Analysis by Early Stage Products, H2 2014Assessment by Monotherapy Products, H2 2014Assessment by Combination Products, H2 2014Number of Products by Top 10 Targets, H2 2014Number of Products by Stage and Top 10 Targets, H2 2014 www.aarkstore.com
List Of Figures Number of Products under Development for Alpha- Antitrypsin Deficiency, H2 2014 9Number of Products under Development for Alpha- Antitrypsin Deficiency - Comparative Analysis, H2 2014 10Number of Products under Development by Companies, H2 2014 11Comparative Analysis by Clinical Stage Development, H2 2014 14Comparative Analysis by Early Stage Products, H2 2014 15Assessment by Monotherapy Products, H2 2014 32Number of Products by Top 10 Targets, H2 2014 33Number of Products by Stage and Top 10 Targets, H2 2014 34Number of Products by Top 10 Mechanism of Actions, H2 2014 35Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 36 www.aarkstore.com
Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com
Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com
Aarkstore - Alzheimers Disease - Pipeline Review, H2 2014 www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com